Brief: Ampio Announces Voluntary Delisting And SEC Deregistration
25/03/2024 21:02
March 25 (Reuters) - Ampio Pharmaceuticals Inc AMPE.A :
* AMPIO ANNOUNCES VOLUNTARY DELISTING AND SEC DEREGISTRATION
* AMPIO PHARMACEUTICALS INC - TODAY NOTIFIED NYSE AMERICAN
OF ITS
INTENTION TO VOLUNTARILY DELIST ITS SHARES OF COMMON STOCK FROM
NYSE AMERICAN
* AMPIO PHARMACEUTICALS INC - DETERMINED TO TAKE STEPS
DESIGNED
TO ENSURE SUFFICIENT CASH TO ADEQUATELY FUND AN ORDERLY WIND
DOWN OF OPERATIONS
Source text for Eikon: ID:nPn3KxYjSa
Further company coverage: AMPE.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ampio Pharmaceuticals
See all newsBrief: Ampio Announces Voluntary Delisting And SEC Deregistration
Brief: Ampio Provides Update On Results From Pre-IND Enabling Studies
Brief: Ampio Selects Ascendia Pharmaceuticals, Inc. To Provide CDMO Services To Support Clinical Development Of OA-201
Brief: Ampio Pharmaceuticals Announces Reverse Stock Split
Brief: Ampio Pharmaceuticals Inc - Holds Approximately $1.25 Million In A Deposit Account At Silicon Valley Bank